← Back to guidelines
Pediatrics3 papers

Congenital bilateral perisylvian syndrome

Last edited: 4/15/2026

Overview

Congenital bilateral perisylvian syndrome (CBPS) is a developmental disorder characterized by bilateral malformations in the perisylvian region, often manifesting as polymicrogyria affecting the sylvian fissure and opercular cortex. It presents with a spectrum of neurological deficits including developmental delay, motor impairments, and speech difficulties 12.

Diagnosis

  • Clinical Features: Developmental delay, poor palatal function, hypotonia, arthrogryposis, hemiparesis, apnea, paraparesis, micrognathia 1.
  • Imaging: MRI is essential, showing bilateral perisylvian polymicrogyria; unilateral schizencephaly with contralateral polymicrogyria may also be observed 1.
  • Histologic Confirmation: In rare cases, autopsy or biopsy may reveal polymicrogyria confirming the diagnosis 2.
  • Management

  • Supportive Care: Focus on managing symptoms including physical therapy for motor impairments, speech therapy for communication difficulties, and nutritional support for feeding issues 1.
  • Seizure Control: Antiepileptic drugs tailored to seizure types and frequency; specific drug classes include valproates, levetiracetam, or others as indicated 1.
  • Respiratory Monitoring: Regular monitoring and management for apnea episodes, possibly requiring respiratory support devices 1.
  • Special Populations

  • Pediatrics: Early intervention is crucial; diagnosis often occurs in early childhood with a median age of 2.25 years 1.
  • Comorbidities: Common comorbidities include hypotonia and arthrogryposis, necessitating multidisciplinary care 1.
  • Key Recommendations

  • MRI for Diagnosis: Routine MRI to identify bilateral perisylvian polymicrogyria or associated anomalies is essential for confirming CBPS (Evidence: Moderate) 1.
  • Early Multidisciplinary Support: Initiate early multidisciplinary management including physical, occupational, and speech therapy to address motor and developmental delays (Evidence: Expert opinion) 1.
  • Seizure Management: Implement individualized antiepileptic drug therapy based on seizure types and frequency to control seizures effectively (Evidence: Moderate) 1.
  • References

    1 Gropman AL, Barkovich AJ, Vezina LG, Conry JA, Dubovsky EC, Packer RJ. Pediatric congenital bilateral perisylvian syndrome: clinical and MRI features in 12 patients. Neuropediatrics 1997. link 2 Shevell MI, Carmant L, Meagher-Villemure K. Developmental bilateral perisylvian dysplasia. Pediatric neurology 1992. link90370-e)

    Original source

    1. [1]
      Pediatric congenital bilateral perisylvian syndrome: clinical and MRI features in 12 patients.Gropman AL, Barkovich AJ, Vezina LG, Conry JA, Dubovsky EC, Packer RJ Neuropediatrics (1997)
    2. [2]
      Developmental bilateral perisylvian dysplasia.Shevell MI, Carmant L, Meagher-Villemure K Pediatric neurology (1992)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG